MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01755nam a2200289Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MX-MdCICY |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250625162459.0 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
CICY |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
B-21011 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250602s9999 xx |||||s2 |||| ||und|d |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Promising role of emodin as therapeutics to against viral infections |
| 490 0# - SERIES STATEMENT |
|---|
| Volume/sequential designation |
Frontiers in Pharmacology, 13, 902626, 2022 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Emodin is an anthraquinone derivative that is widely present in natural plants and has a wide spectrum of pharmacological effects, such as antibacterial, anti-inflammatory, anti-fibrotic and anticancer and so on. Through reviewing studies on antiviral effect of emodin in the past decades, we found that emodin exhibits ability of inhibiting the infection and replication of more than 10 viruses in vitro and in vivo, including herpes simplex virus type 1 (HSV-1)and type 2 (HSV-2), human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), coxsackievirus B (CVB), hepatitis B virus (HBV), influenza A virus (IAV), SARS-CoV, viral haemorrhagic septicaemia rhabdovirus (VHSV), enterovirus 71 (EV71), dengue virus serotype 2 (DENV-2)and Zika virus (ZIKV). Therefore, this review aims to summarize the antiviral effect of emodin, in order to provide reference and hopes to support the further investigations. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
EMODIN |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
VIRUS INFECTION |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
HSV-2 |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
HCMV (HUMAN CYTOMEGALOVIRUS) |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19 |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Shao, Q. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Liu, T. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wang, W. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Liu, T. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Jin, X. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Chen, Z. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://drive.google.com/open?id=1xBA4ZT2x6PR-cJmvxpzlexZ6ECAD7Yvq&usp=drive_copy">https://drive.google.com/open?id=1xBA4ZT2x6PR-cJmvxpzlexZ6ECAD7Yvq&usp=drive_copy</a> |
| Public note |
Para ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Clasificación local |
| Koha item type |
Documentos solicitados |
